Nvidia Stock Has 41% Upside, According to 1 Wall Street Analyst
The Motley Fool· 2024-09-19 22:21
Despite the big run-up in the stock, one Wall Street analyst thinks there is room to run. It's been quite the year for artificial intelligence (AI) chipmaker Nvidia (NVDA 5.13%), which has seen its stock rise more than 161% year to date. Over the last five years, Nvidia's stock is up by more than an astounding 2,560%. In doing so, Nvidia has reached a nosebleed valuation and now trades at 40 times forward earnings. Investors believe that Nvidia's stock doesn't have a ceiling right now, considering the poten ...
Apple Warned By EU About 'Interoperability' Compliance
Investopedia· 2024-09-19 22:20
Key Takeaways The European Union's enforcement arm said Thursday it's initiating a pair of "specification proceedings" into whether Apple is complying with its "interoperability obligations" under the Digital Markets Act. Apple's process of allowing third parties to access iOS while developing products like smartwatches and headphones is under review by the European Commission. The Commission will conclude the investigation within the next six months, and inform Apple of any changes it needs to make. The Eu ...
Apple Revenue Growth 'Just Too Slow For Investors To Get Excited About': Analyst Highlights Advertising As Future Catalyst
Benzinga· 2024-09-19 22:20
An Apple Inc AAPL analyst says the company could turn to advertising revenue and other areas of growth as concerns mount over iPhone 16 demand. The Apple Analyst: Needham analyst Laura Martin reiterated a Buy rating and $260 price target on Apple. The Analyst Takeaways: Apple faces concerns over iPhone 16 demand. Martin points to ways the Cupertino, California-based company could kickstart additional growth, including a focus on advertising revenue. "The top debate is when will the next iPhone replacement c ...
Edgewise Therapeutics Stock Shoots Higher On Promising Early Results For Thickened Heart Treatment
Benzinga· 2024-09-19 22:19
On Thursday, Edgewise Therapeutics Inc. EWTX released announced topline data of EDG-7500 from the Phase 1 trial in healthy subjects and the single-dose arm of the Phase 2 CIRRUS-HCM trial for obstructive hypertrophic cardiomyopathy. Obstructive hypertrophic cardiomyopathy is a heart condition that occurs when the wall between the left and right ventricles of the heart thickens, blocking blood flow from the left ventricle to the body's main artery. In the Phase 1 single ascending dose (SAD) trial (n=48), hea ...
Kinsale: Fantastic Business Fundamentals Are Priced-In
Seeking Alpha· 2024-09-19 22:16
Kinsale Capital Group, Inc. (NYSE: KNSL ) has a very interesting business profile and fundamentals in the E&S segment of the P&C insurance industry, but its superior profitability and business efficiency seem already priced-in.Labutes IR is a Fund Manager/Analyst specialized in the financial sector, with more than 18 years of experience in the financial markets. I have worked at several type of institutions in the industry, always at the buy side and related to portfolio management. Associated with the exis ...
Best Value Stocks to Buy for September 19th
ZACKS· 2024-09-19 22:15
Here are three stocks with buy rank and strong value characteristics for investors to consider today, September 19th:  Cerence (CRNC) : This company which provides A.I. powered assistants and innovations for connected and autonomous vehicles, carries a Zacks Rank #1(Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.0% over the last 60 days.Cerence has a price-to-earnings ratio (P/E) of 2.73 compared with 62.70 for the industry. The company possesses a Va ...
Johnson Controls' Metasys Update Enhances Energy Management
ZACKS· 2024-09-19 22:15
Johnson Controls International plc (JCI) recently unveiled an update to its Building Automation System ("BAS"), Metasys, which is a comprehensive suite of integrated systems and servers that ensures reliable, coordinated control over building energy management. The latest version of the BAS is Metasys 14.0.Metasys 14.0 features advanced analytics tools that help enhance building efficiency with preconfigured energy dashboards, while a flat network architecture supports up to 800 IP devices across various pr ...
5 AI Giants to Watch at Attractive Prices Amid Fed's Big Rate Cut
ZACKS· 2024-09-19 22:15
On Sept. 18, in its FOMC meeting, the Fed reduced the benchmark lending rate by 50 basis points, marking the first cut of the Fed Fund rate since March 2020. Although the first rate cut was certain in September, market participants are surprised about its magnitude. Just before the Fed’s decision, the CME FedWatch tool showed a 100% probability of a 25 basis-point cut and a 65% chance of a 50 basis-point reduction. Fed’s aggressive beginning of the low-interest rate regime has compelled a section of market ...
Lockheed Finishes Risk Reduction Test for TPY-4 Radar: Time to Buy?
ZACKS· 2024-09-19 22:15
Lockheed Martin Corp. (LMT) recently completed the risk reduction testing for the TPY-4 radar, thereby making progress in the Three-Dimensional Expeditionary Long-Range Radar (“3DELRR”) program. Notably, in February 2022, the U.S. Air Force selected Lockheed as the primary contractor for the 3DELRR program to provide a radar that will perform long-range detection of both air-breathing threats and theater ballistic missiles. The selection of Lockheed as the provider of the radar under the 3DELRR program, whi ...
Reasons to Retain EYE Stock in Your Portfolio for Now
ZACKS· 2024-09-19 22:15
National Vision Holdings, Inc.’s (EYE) growth is backed by the consistent market expansion of the Owned and Host segment. The company’s strategic progress in terms of expanding exam capacity, recruitment and retention efforts and remote exam initiatives is highly encouraging. However, weak solvency and an ailing capital structure are concerning. Mounting expenses due to slow economic conditions also add to the worry.In the past year, this Zacks Rank #3 (Hold) company’s shares have lost 33.4% against the ind ...